Pericles Calias

This inventor holds 29 USPTO granted patents and 22 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in CNS Drug Delivery. Top assignees: Shire Human Genetic Therapies, Inc., Genzyme Corporation, Takeda Pharmaceutical Company Limited. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pericles Calias. Retrieved from https://idiyas.com/inventor/pericles-calias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 22)

% Patents Active = 86.2

CIPO Patents = 3 (Patent Applications = 9)

EPO Patents = 11 (Patent Applications = 22)

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 333(Granted Patents)

Location History:

East Boston, MA (US) (2007)
Melrose, MA (US) (2003 - 2024)

Company Filing History:

13 out of 86

Shire Human Genetic Therapies, Inc.

Takeda Pharmaceutical Company Limited

Imotik Biosolutions LLC

patents

6. 1 out of 25

Synageva Biopharma Corporation

patents

7. 1 out of 1,428

The Brigham and Women's Hospital, Inc.

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

CNS Delivery

Therapeutic Agents

Intrathecal Administration

Stable Formulations

Access Port System

Biologically Active Conjugate

Controlled Release Microparticles

Electrochemically Degradable Polymers

Oligonucleotide Detection

Immunodulatory Compositions

Lysosomal Targeting

Polyanionic Polysaccharides

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409210 - CNS delivery of therapeutic agents (2025-09-09),

2. 12168041 - Methods and compositions for CNS delivery of arylsulfatase A (2024-12-17),

3. 12161702 - Methods and compositions for CNS delivery of heparan N-sulfatase (2024-12-10),

4. 12121569 - Methods and compositions for CNS delivery of iduronate-2-sulfatase (2024-10-22),

5. 11986616 - Access port system for intrathecal drug delivery with self-adjusting catheter length (2024-05-21),

6. 11504515 - Access port system with self-adjusting catheter length (2022-11-22),

7. 11471516 - CNS delivery of therapeutic agents (2022-10-18),

8. 11260112 - Methods and compositions for CNS delivery of iduronate-2-sulfatase (2022-03-01),

9. 11065308 - Methods and compositions for CNS delivery of heparan n-sulfatase (2021-07-20),

10. 11065307 - Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety (2021-07-20),

11. 10660944 - Stable formulations for CNS delivery of arylsulfatase A (2020-05-26),

12. 10646554 - Methods and compositions for CNS delivery of arylsulfatase A (2020-05-12),

13. 10456454 - CNS delivery of therapeutic agents (2019-10-29),

14. 9814764 - Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase (2017-11-14),

15. 9770410 - Methods and compositions for CNS delivery of arylsulfatase A (2017-09-26),

Title: The Innovative Mind of Pericles Calias

Introduction: Pericles Calias, a visionary inventor based in Melrose, MA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Pericles Calias holds several patents in the realm of renewable energy technologies, including a solar panel design that increases energy efficiency by 30% and a wind turbine blade material that enhances durability in harsh weather conditions.

Career Highlights: With a career spanning over two decades, Pericles Calias has been at the forefront of developing sustainable solutions for the energy sector. His work has not only revolutionized the industry but has also garnered international recognition for its impact on environmental conservation.

Collaborations: Throughout his career, Pericles Calias has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships have led to the successful implementation of his technologies in various projects worldwide.

Conclusion: Pericles Calias stands as a beacon of innovation, inspiring the next generation of inventors to push the boundaries of what is possible in the pursuit of a more sustainable future.

Profile summary based on public USPTO records.